Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
PK of EPORON vs EPREX in Healthy Male Volunteers
NCT02580006Phase 1Unknown
- Sponsor
- Dong-A ST
- Start
- Nov 2015
- Primary completion
- Jan 2016
- Modality
- Biologic, rProtein (Recombinant Protein)
- Countries
- 1
01
Overview
Phase 1, randomised, double-blind trial of epoetin alfa in anemia (2 arms), sponsored by Dong-A ST. Primary endpoints: Area Under Curve last of Erythropoietin, Maximum concentration of Erythropoietin and 1 more. Status: unknown.
02
Drugs
epoetin alfa
03
Conditions
anemia
Beyond the preview
Go deeper on NCT02580006.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02580006.